 Bank of New York Mellon Corp grew its position in shares of Eiger Biopharmaceuticals Inc NASDAQ:EIGR by 2.6 during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 76,085 shares of the biotechnology companys stock after buying an additional 1,926 shares during the quarter. ... 